These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3866254)

  • 21. Vasoactive intestinal polypeptide and alpha 2-adrenoceptor agonists regulate adenosine 3',5'-monophosphate accumulation and melatonin release in chick pineal cell cultures.
    Pratt BL; Takahashi JS
    Endocrinology; 1989 Nov; 125(5):2375-84. PubMed ID: 2477231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enaminones and norepinephrine employ convergent mechanisms to depress excitatory synaptic transmission in the rat nucleus accumbens in vitro.
    Kombian SB; Ananthalakshmi KV; Edafiogho IO
    Eur J Neurosci; 2006 Nov; 24(10):2781-8. PubMed ID: 17156204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of different forms of vasoactive intestinal peptide on cAMP formation in the mammalian cerebral cortex.
    Dejda A; Gendek-Kubiak H; Nowak JZ
    Pol J Pharmacol; 2004; 56(4):421-5. PubMed ID: 15520496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A synergistic interaction between histamine and vasoactive intestinal peptide (VIP) on cyclic AMP production in the chick pineal gland.
    Nowak JZ; Woldan-Tambor A; Kuba K; Zawilska JB
    J Physiol Pharmacol; 1998 Sep; 49(3):377-86. PubMed ID: 9789791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A role for neurotransmitters in early follicular development: induction of functional follicle-stimulating hormone receptors in newly formed follicles of the rat ovary.
    Mayerhofer A; Dissen GA; Costa ME; Ojeda SR
    Endocrinology; 1997 Aug; 138(8):3320-9. PubMed ID: 9231784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morphological and functional correlates of VIP neurons in cerebral cortex.
    Magistretti PJ; Morrison JH; Shoemaker WJ; Bloom FE
    Peptides; 1984; 5(2):213-8. PubMed ID: 6473153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intercellular communication mediated by VIP in the cerebral cortex.
    Magistretti PJ
    Peptides; 1986; 7 Suppl 1():169-73. PubMed ID: 2875443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasoactive intestinal polypeptide excitation of central neurons.
    Phillis JW; Kirkpatrick JR; Said SI
    Can J Physiol Pharmacol; 1978 Apr; 56(2):337-40. PubMed ID: 416895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of ion transport in porcine gallbladder: effects of VIP and norepinephrine.
    O'Grady SM; Wolters PJ; Hildebrand K; Brown DR
    Am J Physiol; 1989 Jul; 257(1 Pt 1):C52-7. PubMed ID: 2546435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide receptors in chick cerebral cortex.
    Zawilska JB; Niewiadomski P; Nowak JZ
    J Mol Neurosci; 2003 Apr; 20(2):153-62. PubMed ID: 12794309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual receptor regulation of cyclic nucleotides: alpha 1-adrenergic potentiation of vasoactive intestinal peptide stimulation of pinealocyte adenosine 3',5'-monophosphate.
    Chik CL; Ho AK; Klein DC
    Endocrinology; 1988 Apr; 122(4):1646-51. PubMed ID: 2831037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of vasoactive intestinal polypeptide (VIP) on rabbit cavernosal smooth muscle contractility.
    Kim YC; Choi HK; Ahn YS; Kim KH; Hagen PO; Carson CC
    J Androl; 1994; 15(5):392-7. PubMed ID: 7860419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New evidence for a gating action of norepinephrine in central neuronal circuits of mammalian brain.
    Waterhouse BD; Sessler FM; Cheng JT; Woodward DJ; Azizi SA; Moises HC
    Brain Res Bull; 1988 Sep; 21(3):425-32. PubMed ID: 3214748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for vasoactive intestinal polypeptide (VIP) altering the firing rate of preoptic, septal and midbrain central gray neurons.
    Haskins JT; Samson WK; Moss RL
    Regul Pept; 1982 Feb; 3(2):113-23. PubMed ID: 7063752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L; Ahrén B; Edgren G; Degerman E
    Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Norepinephrine modulates the effect of neuropeptides in coeliac ganglion on ovarian hormones release: its relationship with ovarian nitric oxide and nerve growth factor.
    Garraza MH; Forneris M; Virginia Gatica L; Oliveros LB
    Neuro Endocrinol Lett; 2010; 31(1):103-12. PubMed ID: 20150881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vasoactive intestinal peptide and noradrenaline exert long-term control on glycogen levels in astrocytes: blockade by protein synthesis inhibition.
    Sorg O; Magistretti PJ
    J Neurosci; 1992 Dec; 12(12):4923-31. PubMed ID: 1334506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vasoactive intestinal peptide increases intracellular calcium in astroglia: synergism with alpha-adrenergic receptors.
    Fatatis A; Holtzclaw LA; Avidor R; Brenneman DE; Russell JT
    Proc Natl Acad Sci U S A; 1994 Mar; 91(6):2036-40. PubMed ID: 8134346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurotransmitter modulation of VIP release from cat cerebral cortex.
    Wang JY; Yaksh TL; Harty GJ; Go VL
    Am J Physiol; 1986 Jan; 250(1 Pt 2):R104-11. PubMed ID: 2867688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An antagonist to vasoactive intestinal peptide affects cellular functions in the central nervous system.
    Gozes I; McCune SK; Jacobson L; Warren D; Moody TW; Fridkin M; Brenneman DE
    J Pharmacol Exp Ther; 1991 Jun; 257(3):959-66. PubMed ID: 1646331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.